Rocket Pharma Says EMA Grants PRIME Designation For RP-A501 Gene Therapy For Danon Disease

Rocket Pharma Says FDA Grants Fast Track And Orphan Drug Designations For RP-A601 Gene Therapy

Biotechnology company Rocket Pharmaceuticals, Inc. (RCKT) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Fast Track and Orphan Drug designations to RP-A601, the Company's gene therapy candidate for the treatment of plakophilin-2 related arrhythmogenic cardiomyopathy (PKP2-ACM).

RTTNews | 761日前

U.S. Small Business Confidence Erodes Slightly In June, Taxes Main Concern - NFIB

Small business sentiment in the U.S. eased slightly in June as uncertainty remains elevated despite easing, and taxes remained a top concern for business owners, survey data from the National Federation of Independent Businesses showed on Tuesday.

RTTNews | 10分前

Sensex, Nifty End Modestly Higher As Trump Extends Trade Deal Deadline

Indian shares eked out modest gains on Tuesday as U.S. President Donald Trump delayed imposing higher tariffs on U.S imports and indicated he would make further climbdowns on tariffs.

RTTNews | 28分前

UK Stocks Turning In Mixed Performance In Cautious Trade

U.K. stocks are turning in a mixed performance Tuesday morning as investors are treading cautiously, keeping track of U.S. President Donald Trump's tariff plans and the potential risks to global economic growth.

RTTNews | 47分前

CAC 40 Slightly Lower In Lackluster Trade

French stocks are slightly lower on Tuesday with investors making cautious moves while closely following the developments on the trade front.

RTTNews | 1時34分前

Australia Central Bank Unexpectedly Maintains Status Quo

The Reserve Bank of Australia adopted a wait-and-see approach on Tuesday, defying expectations for a quarter-point rate cut but confirmed that an easing cycle is coming. The policy board, governed by Michele Bullock, decided to hold the cash rate target at 3.85 percent. A majority of six members voted to hold the rate, while three members sought a change from 3.85 percent.

RTTNews | 1時45分前

European Shares Little Changed As Investors Assess Trump's Tariff Plans

European shares were little changed on Tuesday as investors weighed U.S. President Donald Trump's tariff plans and global growth risks.

RTTNews | 1時57分前

Asian Shares Climb As Investors Brush Off Trump's Tariff Threats

Asian stocks ended mostly higher on Tuesday as U.S. President Donald Trump gave an additional three-week grace period for tariff negotiations after unveiling new tariff rates for 14 trading partners.

RTTNews | 2時15分前

EURUSD	1.17255	GBPUSD	1.35798	AUDUSD	0.65394
USDJPY	146.382	USDCAD	1.36545	USDCHF	0.7975

Advertisement

Rocket Pharma Says EMA Grants PRIME Designation For RP-A501 Gene Therapy For Danon Disease